Ipamorelin Research Peptide: Trace Identity Backward

A literature name, database record, and seller label are separate sources. This page explains how to trace their identity fields without treating them as one material.

Start at the cited name, then trace backward

The phrase ipamorelin research peptide often begins with a seller label, while the strongest available identity information may sit elsewhere: in a primary paper’s material wording and sequence, or in a curated chemical record. The trace should run backward from the literature name to the stated sequence or structure, then forward only when an actual material record connects a physical item to that identity.

This sequence matters because the word “ipamorelin” alone does not identify a particular synthesis, salt or counterion, amount, container, supplier, or lot. Likewise, a database entry does not establish that a vendor’s item was the material in a cited study. The connection must be documented, not assumed from a shared name.

Break point one: does the primary paper identify its material beyond the name?

Raun et al. described ipamorelin as the pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2 in their original pharmacology report. The same abstract places that named material in primary rat pituitary-cell, rat, and swine research systems. For identity tracing, the important starting fields are the exact term “ipamorelin” and the stated pentapeptide sequence; the study does not identify a later catalogue lot. ^[1]

A paper that names a peptide but omits a sequence, modification, or other identity field has a weaker starting point. Its reported model and endpoint may still be valid for that paper, but a reviewer should not silently add the missing identity detail from a similarly named product page. The source should be logged as name-only for the unresolved field.

Break point two: does the chemical record match the cited identity?

PubChem Compound CID 9831659 is titled ipamorelin and presents a chemical-structure record, including molecular formula, molecular weight, canonical structure text, and an InChIKey. Its role in this trace is a structure-reference point. The reviewer should compare the source’s stated sequence and modifications with the record’s public chemical-identity fields, retaining both identifiers and the date checked. ^[2]

PubChem maintains separate Compound and Substance databases: the former holds unique chemical structures, while the latter includes depositor-provided chemical-substance descriptions. This explains why a CID and a seller-facing or depositor-source record must remain distinguishable even when they use the same name. ^[3]

Break point three: is there a chain from a public identity record to the physical item?

PubChem Substance SID 103244932 lists ipamorelin, the synonym NNC 26-0161, and the source ChEMBL with source identifier CHEMBL58547. That is a public substance record with a named contributing source. It is not a certificate for an arbitrary seller, a current catalogue page, a lot number, or a test result for a received vial. ^[4]

For a seller’s item, the missing connection is normally resolved only by records specific to that item: the contemporaneous label or catalogue identifier, a lot or batch identifier, and any dated accompanying document that names the same material and lot. Without that chain, the accurate conclusion is that the item is labelled “ipamorelin research peptide”; it is not that the item has been shown to be the paper’s test material or the database structure.

Two outcomes from the same tracing method

Documented literature-to-identity path: the Raun record supplies the name and pentapeptide sequence; CID 9831659 supplies a public compound-identity record for ipamorelin; and SID 103244932 supplies a separate source-specific Substance record. This path supports a careful comparison of the cited name, sequence, and public identifiers. It still stops before a physical supplier lot unless a lot-linked document completes that final connection.

Name-only seller path: a catalogue page states “ipamorelin research peptide” but provides no lot number, no dated document naming the received item, and no analytical identity field. The page supports its own label wording and catalogue identifier. It does not complete the link to PMID 9849822, CID 9831659, or SID 103244932. Marking the link as unverified is more accurate than importing a sequence or result from another record.

End the trace with fields, not an equivalence claim

A usable research note retains the original paper citation and exact material wording; the sequence or modification field if the paper reports one; every public identifier checked; the database record date; the seller’s page or label version; the physical lot identifier; and the exact lot-linked documents available. It also records which link remains missing. This final list is an identity-trace record, not a certificate of purity, performance, safety, or suitability.

CJC-1295 and Ipamorelin: A Material-Identity Guide addresses the separate question of distinguishing a combined material from its named components. Reviewing COA, MSDS & batch records addresses document matching once a physical item and lot are available. Neither page joins a public name to a specific batch without direct evidence.

Sources

1. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998;139:552-561. PMID 9849822. PubMed record.
2. PubChem. Ipamorelin, CID 9831659. PubChem Compound record.
3. Kim S, Thiessen PA, Cheng T, et al. Literature information in PubChem: associations between PubChem records and scientific articles. Journal of Cheminformatics. 2016;8:32. PMID 27293485; PMCID PMC4901473. Full text in PMC.
4. PubChem. Ipamorelin, SID 103244932; source ChEMBL; source identifier CHEMBL58547. PubChem Substance record.

This summary reports study details from the cited source and does not provide medical, veterinary, dosing, administration, safety, or treatment guidance. It does not represent a product-use recommendation.

Catalogue boundary: The related ipamorelin research material page is a seller listing. It does not link a physical lot to the Raun paper, CID, or SID without a dated lot-specific document. This page targets the exact keyword ipamorelin research peptide through the backward identity trace.